Open original FDA record ↗Recall record
- FDA identifier
- Z-0916-2015
- Company in FDA record
- Boston Scientific Corporation
- FDA classification date
- Jan 13, 2015
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class I
Reason stated in the source
Lotus valve became unlocked during release from the delivery system. This may lead to percutaneous insertion of another valve, resulting in a Valve in Valve (ViV) implantation. If this occurs, the first valve could embolize and it may be necessary to convert the patient to surgery.
Source facts
- Action
- Boston Scientific notified consignees on November 19, 2014, of the problem via letter through overnight delivery directing consignees to segregate and return affected product to Boston Scientific utilizing the Field Safety Corrective Action (FSCA) Instructions provided. The FSCA details that consignees should: Immediately discontinue use of and segregate product; Complete and return the Account Reply Verification Tracking form and Package/Ship the affected product.
- Initiated
- 2014-11-19
- Root cause
- Device Design
- Terminated
- 2015-03-26
- Distribution
- Distributed only in the countries of Finland, France, Germany, Great Britain, Italy, Norway, Spain, Sweden, and Switzerland.
- Recall number
- Z-0916-2015
- Recall status
- Terminated
- CDRH record ID
- 131994
- FDA classified
- 2015-01-13
- Recall event number
- 69931